Docking and three-dimensional quantitative structure–activity relationship analyses of imidazole and thiazolidine derivatives as Aurora A kinase inhibitors

作者: Chaeuk Im

DOI: 10.1007/S12272-016-0870-1

关键词:

摘要: Aurora A kinase is involved in the inactivation of apoptosis leading to ovarian, breast, colon, and pancreatic cancers. Inhibitors promote aberrant mitosis resulting arrest at a pseudo G1 state induce mitotic catastrophe, ultimately apoptosis. In this study, ligand-based docking-based three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses imidazole thiazolidine derivatives as potential inhibitors were performed. The results provided highly reliable predictive 3D-QSAR comparative molecular similarity index analysis (CoMSIA) models with cross-validated q2 value 0.768, non-cross-validated r2 0.983, coefficient [Formula: see text] 0.978. CoMSIA contour maps suggested that NH benzyl hydroxy groups R9, CO group ring pyridine important components for biological activity. also suggest introduction C2 imino-phenyl ring, C5 or substitution imino-2-pyridine could be applied enhance

参考文章(25)
Ajay N. Jain, Morphological similarity: a 3D molecular similarity method correlated with protein-ligand recognition. Journal of Computer-aided Molecular Design. ,vol. 14, pp. 199- 213 ,(2000) , 10.1023/A:1008100132405
Paschalis Gavriilidis, Alexandros Giakoustidis, Dimitrios Giakoustidis, Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review Journal of Clinical Medicine Research. ,vol. 7, pp. 742- 751 ,(2015) , 10.14740/JOCMR2295W
Carlos F. Lagos, Julio Caballero, Fernando D. Gonzalez-Nilo, Carlos David Pessoa-Mahana, Tomas Perez-Acle, Docking and Quantitative Structure-Activity Relationship Studies for the Bisphenylbenzimidazole Family of Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase Chemical Biology & Drug Design. ,vol. 72, pp. 360- 369 ,(2008) , 10.1111/J.1747-0285.2008.00716.X
M Kimura, T Yoshioka, M Saio, Y Banno, H Nagaoka, Y Okano, Mitotic catastrophe and cell death induced by depletion of centrosomal proteins Cell Death and Disease. ,vol. 4, ,(2013) , 10.1038/CDDIS.2013.108
Ajay N. Jain, Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. Journal of Medicinal Chemistry. ,vol. 46, pp. 499- 511 ,(2003) , 10.1021/JM020406H
Susanne M. A. Lens, Emile E. Voest, René H. Medema, Shared and separate functions of polo-like kinases and aurora kinases in cancer Nature Reviews Cancer. ,vol. 10, pp. 825- 841 ,(2010) , 10.1038/NRC2964
Jayne Curry, Hayley Angove, Lynsey Fazal, John Lyons, Matthias Reule, Neil Thompson, Nicola Wallis, Aurora B kinase inhibition in mitosis: Strategies for optimizing the use of Aurora kinase inhibitors such as AT9283 Cell Cycle. ,vol. 8, pp. 1921- 1929 ,(2009) , 10.4161/CC.8.12.8741
E. Claire Dees, Jeffrey R. Infante, Roger B. Cohen, Bert H. O’Neil, Suzanne Jones, Margaret von Mehren, Hadi Danaee, Yih Lee, Jeffrey Ecsedy, Mark Manfredi, Katherine Galvin, Bradley Stringer, Hua Liu, Omar Eton, Howard Fingert, Howard Burris, Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors Cancer Chemotherapy and Pharmacology. ,vol. 67, pp. 945- 954 ,(2011) , 10.1007/S00280-010-1377-Y
Paraskevi Briassouli, Florence Chan, Kay Savage, Jorge S. Reis-Filho, Spiros Linardopoulos, Aurora-A Regulation of Nuclear Factor-κB Signaling by Phosphorylation of IκBα Cancer Research. ,vol. 67, pp. 1689- 1695 ,(2007) , 10.1158/0008-5472.CAN-06-2272
John R. Pollard, Michael Mortimore, Discovery and development of aurora kinase inhibitors as anticancer agents. Journal of Medicinal Chemistry. ,vol. 52, pp. 2629- 2651 ,(2009) , 10.1021/JM8012129